New contemporary technology from Hill-Rom Holdings is made to more easily clear airways for sufferers with cystic fibrosis, and let the clinicians know at a distance how sufferers are responding to the proposed treatment.
The product, known as the VisiVest System, utilizes high-frequency chest-wall oscillation, which assists to clear the mucus from lung airways. It comes out with the wireless connectivity from the Qualcomm that sends information to a portal from Razorfish that reflects the information trends to clinicians through a dashboard.
The information also is present to sufferers so they can help in treatment decisions with the aim of better therapy adherence, in accordance to Hill-Rom.Full introduction of VisiVest followed a 6-month pilot test with 160 sufferers from 7 clinics specializing in the treatment of cystic fibrosis.
“What I like much about the VisiVest System is being capable to see my sufferers’ session information and trends,” Tom Newton, a pulmonary therapist at Miller Children’s Hospital in Long Beach, Calif. “Now, I am not merely telling my sufferers the more adherent they’re to their therapy the larger their pulmonary function numbers are likely to be. We can really look at their adherence score accumulatively and have a more detailed conversation about their numbers.”
No comments:
Post a Comment